Big Pharma R&D Chiefs On IRA’s Unintended Casualty, Product Life Cycle Compression

 
• By Anju Ghangurde
  
Will IRA provisions derail small molecules R&D? • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from R&D

More from Scrip